C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage ALNT Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Gain TLSI Q1 2026 Earnings EPS Surprises Positively Despite No Revenue Stock Declines Expion360 Q2 2025 Earnings EPS Surpasses Estimates as Narrower Loss Signals Cost Discipline EZRA Q1 2023 Earnings Massive EPS Beat Drives Stock Surge LNG Q1 2026 Earnings Massive EPS Miss as Company Reports Loss of 1675 per Share